Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.58 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | REN | P00797 | 2/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.49 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30304798 | 0.95 | OPRM1 (0.58) | OPRM1CALCRLSLC6A2OPRD1 | |
| SCHEMBL30304785 | 0.93 | OPRM1 (0.53) | OPRM1CALCRLSLC6A2RENOPRD1 | |
| SCHEMBL29591583 | 0.89 | SLC6A2 (0.59) | OPRM1CALCRLSLC6A2OPRD1 | |
| SCHEMBL29590967 | 0.89 | SLC6A2 (0.59) | OPRM1CALCRLSLC6A2OPRD1 | |
| SCHEMBL30050570 | 0.88 | OPRM1 (0.54) | OPRM1CALCRLSLC6A2RENOPRD1 | |
| SCHEMBL29591825 | 0.88 | OPRM1 (0.60) | OPRM1SLC6A2OPRD1 | |
| SCHEMBL30304870 | 0.87 | SLC6A2 (0.56) | OPRM1CALCRLSLC6A2OPRD1 | |
| SCHEMBL29590992 | 0.86 | OPRM1 (0.59) | OPRM1SLC6A2OPRD1 | |
| SCHEMBL29737437 | 0.85 | SLC6A2 (0.58) | OPRM1CALCRLSLC6A2RENOPRD1 | |
| SCHEMBL16316739 | 0.85 | SLC6A2 (0.63) | OPRM1CALCRLSLC6A2RENOPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116063379-B | EphA2 targeting polypeptides and uses thereof | 中国药科大学 | 2025-05-02 | — | — | CN | disclosed |
| CN-116063379-A | EphA2 targeting polypeptides and uses thereof | 中国药科大学 | 2023-05-05 | — | — | CN | disclosed |